Daniel Perl
Gastroenterology · New York, NYNPI 1497133433
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 379 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by AbbVie at 33.2% of the total.
Across 379 payments — averaging $24.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- QOL Medical, LLC$1K
- Johnson & Johnson$743
- Regeneron Healthcare Solutions, Inc.$509
- Sanofi$499
- Takeda Pharmaceuticals U.S.A., Inc.$471
- plus $3K from 23 others
What the payments were for
- Food & beverage$9,329100%
- Education$170%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 149 | $3,105 |
| QOL Medical, LLC | 29 | $1,030 |
| Johnson & Johnson | 22 | $743 |
| Regeneron Healthcare Solutions, Inc. | 19 | $509 |
| Sanofi | 11 | $499 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $471 |
| Pfizer | 22 | $413 |
| Ardelyx, Inc. | 19 | $386 |
| Redhill Biopharma Inc. | 16 | $297 |
| Bristol Myers Squibb | 14 | $293 |
| Braintree Laboratories, Inc. | 12 | $289 |
| E.r. Squibb & Sons, L.L.C. | 2 | $265 |
| Ironwood Pharmaceuticals, Inc | 8 | $177 |
| Lilly USA, LLC | 7 | $175 |
| Ferring Pharmaceuticals Inc. | 5 | $128 |
| Madrigal Pharmaceuticals | 3 | $89 |
| Celltrion USA Inc. | 4 | $81 |
| Gilead | 4 | $77 |
| Viiv Healthcare Company | 2 | $61 |
| Nestle Healthcare Nutrition Inc. | 2 | $45 |
| Phadia US Inc. | 2 | $33 |
| Phathom Pharmaceuticals, Inc. | 1 | $28 |
| Shield Therapeutics Inc | 1 | $26 |
| Galderma Laboratories, L.p. | 1 | $24 |
| Mayne Pharma Commercial LLC | 1 | $23 |
| Evoke Pharma, Inc. | 1 | $23 |
| Oxford Immunotec USA Inc | 1 | $22 |
| Capsovision, Inc. | 1 | $20 |
| Alfasigma USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,346 in reported general payments places this provider in the 75th percentile of 1,682 gastroenterology providers in New York.
Other gastroenterology in New York
- David Carr LockeNew York$2M
- Arthur KornbluthNew York$1.9M
- Sonal KumarNew York$1M
- David PoppersNew York$939K
- Ellen ScherlNew York$857K
- Bruce SandsNew York$810K
- Jean Frederick ColombelNew York$786K
- Seth GrossNew York$624K
- Caterina Oneto ArayaNew York$610K
- Dana LukinNew York$491K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.